Özlem DEVRİM BALABAN, MURAT İLHAN ATAGÜN, Halise DEVRİMCİ-ÖZGÜVEN, Hüseyin Hamdi ÖZSAN

Psychiatric morbidity in patients with vitiligo

Amaç: Bu çalışmanın amacı, dermatoloji polikliniğinde ayakta tedavi gören vitiligolu hastalarda psikiyatrik mor bidite sıklığını saptamak ve bu hastalardaki kaygı, depresyon ve sosyal kaygı düzeyleri ile benlik saygısı ve yeti yitimi arasındaki ilişkiyi incelemektir. Yöntem: Çalışmaya alınan 42 vitiligo hastası, DSM-IV Eksen I Bozuklukları İçin Yapılandırılmış Klinik Görüşme (SCID-I), Hastane Anksiyete ve Depresyon Ölçeği (HADÖ), Rosenberg Benlik Saygısı Ölçeği (RBSÖ), Liebowitz Sosyal Kaygı Ölçeği (LSKÖ) ve Sheehan Yeti Yitimi Ölçeği (SYYÖ) ile değerlendirilmiştir. Kontrol grubu, hasta grubu ile yaş, cinsiyet ve eğitim düzeyi bakımından benzer olan 33 sağlıklı gönüllüden oluşturulmuştur. Bulgular: Vitiligo grubunda, kontrol grubuna göre psikiyatrik morbidite sıklığı daha yüksek, benlik saygısı belir gin olarak daha düşük saptanmıştır. Sosyal kaygı, kontrol grubundakinden farklı olmayıp, yeti yitimi vitiligo olgu larının çoğunda hafif derecede bildirilmiştir. Vitiligo olguları içinde gençlerde ve kadınlarda psikiyatrik morbidi te daha sık saptanmıştır. Yaş ile kaygı ve sosyal kaçınma puanları arasında negatif korelasyon tespit edilmiştir. Sonuç: Bulgular, vitiligo olgularında psikiyatrik morbidite sıklığının sağlıklı kontrol grubuna kıyasla daha yüksek olduğunu göstermektedir. Dermatoloji polikliniklerine başvuran vitiligo olguları psikiyatrik açıdan değerlendi rilmeli, gerekli durumlarda hastaların psikiyatrik destek alması sağlanmalıdır.

Vitiligolu hastalarda psikiyatrik morbidite

Objective: The aim of this study was to determine the frequency of psychiatric morbidity in vitiligo patients treated at the dermatology outpatient clinic and to investigate the relation between anxiety, depression, social anxiety levels, and self esteem and disability in these patients. Method: Fourty-two patients with vitiligo were assessed with Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Hospital Anxiety Depression Scale (HADS), Rosenberg Self-Esteem Scale (RSES), Liebowitz Social Anxiety Scale (LSAS) and Sheehan Disability Scale (SDS). Control group included subjects matched to patients in terms of age, sex and education level. Results: In comparison to healthy controls, the rate of psychiatric morbidity was found to be higher and mean self-esteem score was found to be lower in the vitiligo group. There was no significant difference between groups in terms of social anxiety. Majority of the patients were mildly disabled. Among the vitiligo cases, psychiatric morbidity was found more frequent in female and young participants. Anxiety and social avoidance scores negatively correlated with age. Conclusion: These findings suggest that the rate of psychiatric morbidity is higher in patients with vitiligo than healthy control subjects. Patients with vitiligo treated at dermatology clinics should be assessed in terms of psychiatric disorders and psychiatric interventions may become necessary in the course of illness.

PDF

___

1. Domonkos AN. Pruritus, Cutaneous neuroses and Neurocutaneous dermatoses: In Anrews GC, Domonkos AN (editors). Andrew’s Disease of the skin: clinical dermatology. 6th ed. Philadelphia: WB Sounders Co., 1971, 61-76.
2. Koblenzer CS. Psychosomatic concepts in dermatology. Arch Dermatol 1983; 119:501-512.
3. Mercan S, Altunay Kıvaç İ. Psychodermatology: a collaboration between psychiatry and dermatology. Turkish Journal of Psychiatry 2006; 17:305-313.
4. Kieć-Swierczyńska M, Dudek B, Krecisz B, Swierczyńska- Machura D, Dudek W, Garnczarek A, Turczyn K. The role of psychological factors and psychiatric disorders in skin diseases. Med Pr 2006; 57:551-555.
5. Hann SK, Kim YS, Yoo JH, Chun YS. Clinical and histological characteristic of trichrome vitiligo. J Am Acad Dermatol 2000; 42:589-596.
6. Silvan M. The psychological aspects of vitiligo. Cutis 2004; 73:163-167.
7. Mattoo SK, Handa S, Kaur I, Gupta N, Malhotra R. Psychiatric morbidity in vitiligo: prevalence and correlates in India. J Eur Acad Dermatol Venereol 2002; 16:573-578.
8. Locala JA. Current concepts in psychodermatology. Curr Psychiatry Rep 2009; 11:211-218.
9. Porter J, Beuf A. Response of old people to impaired appearance: The effect of age on disturbance by vitiligo. J Aging Stud 1988; 2:167-181.
10. Koshevenko IN. The psychological characteristics of patients with vitiligo. Vestn Dermatol Venerol 1989; 5:4-6.
11. Sukan M, Maner F. Vitiligo ve kronik ürtiker hastalarında psikiyatrik eş tanı. Anadolu Psikiyatri Dergisi 2007; 8:30-36 (Article in Turkish).
12. Osman AM, Elkordufani Y, Abdullah MA. The psychological impact of vitiligo in adult Sudanese patients. Afr J Psychiatry 2009; 12:284-286.
13. Jafferany M. Psychodermatology: a guide to understanding common psychocutaneous disorders. Prim Care Companion J Clin Psychiatry 2007;203-213.
14. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV Axis 1 Disorders. New York: New York State Psychiatric Institute, Biometrics Research Department, 1997.
15. Özkürkçügil A, Aydemir Ö, Yıldız M, Danacı E, Köroğlu E. DSM-IV eksen I bozuklukları için yapılandırılmış klinik görüşmenin Türkçeye uyarlanması ve güvenilirlik çalışması. İlaç ve Tedavi Dergisi 1999; 12:233-236 (Article in Turkish).
16. Zigmond AS, Snaith PR. The Hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67:361-370.
17. Aydemir Ö, Güvenir T, Küey L, Kültür S. Hastane anksiyete ve depresyon ölçeği Türkçe formunun geçerlilik ve güvenilirliği. Turk Psikiyatri Derg 1997; 8:280-287 (Article in Turkish).
18. Rosenberg M. Society and Adolescent Self-Image. New Jersey: Princeton University Press, 1965.
19. Çuhadaroğlu F. Adolesanlarda benlik saygısı. Uzmanlık Tezi, Hacettepe Üniversitesi Tıp Fakültesi, Ankara, 1986 (Thesis in Turkish).
20. Heimberg RG, Horner KJ, Juster HR, Safren SA, Brown EJ, Schneier FR, Liebowitz MR. Psychometric properties of the Liebowitz Social Anxiety Scale. Psychol Med 1999; 29:199-212.
21. Soykan C, Ozguven HD, Gencoz T. Liebowitz Social anxiety scale: the Turkish version. Psychol Rep 2003; 93:1059-1069.
22. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol 1996; 11:89-95.
23. Devrimci-Özgüven H, Kundakçı N, Kumbasar H, Boyvat A. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol 2000; 14:267-271.
24. Çalıkoğlu E, Önder M, Coşar B, Candansayar S. Depression, anxiety levels and general psychological profile in Behçet’s Disease. Dermatology 2001; 203:238-240.
25. Fritzsche K, Ott J, Zschocke I, Scheib P, Burger T, Augustin M. Psychosomatic liaison service in dermatology. Dermatology 2001; 203:27-31.
26. Picardi A, Abeni D, Melchi CF, Puddu P, Pasquini P. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000; 143:983-991.
27. Sharma N, Koranne RV, Singh RK. Psychiatric morbidity in psoriasis and vitiligo: a comparative study. J Dermatol 2001; 28:419-423.
28. Yarpuz AY, Saadet ED, Şanlı HE, Özgüven HD. Social anxiety level in acne vulgaris patients and its relationship to clinical variables. Turkish Journal of Psychiatry 2008; 19:29-37.
29. Porter J, Beuf AH, Nordlund JJ, Lerner AB. Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen Hosp Psychiatry 1979; 1:73-77.
30. Parsad D, Dogra S, Kanwar AJ. Quality of life in patients with vitiligo. Health Qual Life Outcomes 2003; 1:58.
31. Sukan M, Maner F. Vitiligo ve kronik ürtiker hastalarında kendilik saygısı. Türkiye’de Psikiyatri 2006; 8:93-97 (Article in Turkish).
32. Hill-Beuf A and Porter JDR. Children coping with impaired appearance. Social and psychologic influences. Gen Hosp Psychiatry 1984; 6:294-300.
33. Papadopoulos L, Bor R, Legg C. Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy. Br J Med Psychol 1999; 72:385-396.
34. Heason S and Kent G. Vitiligo: More than a skin disease. University of Sheffield, UK. http://www.shef.ac.uk/content/1/ c6/10/39/59/heason.pdf.
35. Prcic S, Durovic D, Duran V, Vukovic D, Gajinov Z. Some psychological characteristics of children and adolescents with vitiligo - Our results. Med Pregl 2006; 59:265-269.
36. Özgüven DH, Kudakçı N, Boyvat A. Psöriyazis hastalarında ikincil sosyal anksiyete. Turk Psikiyatri Derg 2000; 11:121-126 (Article in Turkish).
37. Wessley SC, Lewis GH. The classification of psychiatric morbidity in attenders at a dermatology clinic. Br J Psychiatry 1989; 155:686-691.
38. Kent G, Al-Abadie M. Psychologic effects of vitiligo: a critical incident analysis. J Am Acad Dermatol 1996; 35:895-898.
39. Porter JR, Beuf AH. Racial variation in reaction to physical stigma: a study of degree of disturbance by vitiligo among black and white patients. J Health Soc Behav 1991; 32:192-204.